[PDF] Top 20 Efficacy and safety of formoterol versus montelukast as add on therapy in moderate persistent asthma

... improving asthma control and airway functions when inhaled corticosteroids alone are ...LABAs, formoterol and salmeterol, do not exhibit in vivo antiinflamatory activity and thus not advocated for use as ... See full document

... Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes Joshua J. Neumiller, PharmD, CDE, FASCP T ype 2 diabetes is a complex and progressive disease characterized by ... See full document

... the efficacy and safety of add-on treatment with AZD1981, a selective orally active CRTh2 antagonist, in patients who were symptomatic despite main- tenance therapy with ...Only asthma ... See full document

... pharmacological therapy for type ...the efficacy and safety of newly approved anti-diabetic drugs Canagliflozin compared to Sitagliptin and Glimepiride patient with type II ...an efficacy ... See full document

... to moderate decreases in alanine aminotransferase, gamma-glu- tamyltransferase, and serum urate were noted in addition to increases in bilirubin, blood urea nitrogen, and ... See full document

... comparative efficacy of these two groups of drugs is largely ...like formoterol and an LTRA like montelukast on lung function, when added to low dose ICS like budesonide in persistent ... See full document

... the efficacy between long‑acting beta 2‑agonists and leukotriene receptor antagonists as add‑on therapy to inhaled corticosteroids in moderate persistent ...with asthma in the ... See full document

... The lung functions although not improved significantly but they were static throughout the study duration. So the overall impressions of both the regimens are equally effective in preventing further decline in lung ... See full document

... Abstract: Asthma is a disease of all ...of asthma in the most advanced ages is similar to that in younger ...ages. Asthma in the elderly may show similar functional and clinical characteristics to ... See full document

... Drug therapy and follow up A rational approach to pharmacotherapy of bronchial asthma is to use ‘relievers’ such as bronchodilators and ‘controllers’ like anti-inflammatory ...with moderate bronchial ... See full document

... COPD is a common, deadly, yet treatable condition that can be seen by every family physician. There are many options available to reduce symptoms and improve the availability of patients to function normally. Drug-x may ... See full document

... There were no major adverse events noted during the study period. Lab parameters SGPT, SGOT, Urea, Creatinine, and CPK, all were within normal limits in all the groups studied. Minor self limiting adverse effects like ... See full document

... clinical efficacy and safety of curcumin capsules as an add on therapy in patients of mild to moderate asthma and proved therapeutic improvement in FEV1 values along with ... See full document

... eosinophilic asthma experience frequent exacerbations and reduced lung function leading to poor health-related quality of ...for add-on maintenance therapy in patients with severe eosinophilic ... See full document

... plus montelukast relative to placebo plus montelukast was 100 mL (95% CI, ...combination therapy when administered in the second ...with montelukast for 4 weeks had ...of montelukast, ... See full document

... relatively low (72–75% across the treatment groups), sug- gesting that a notable proportion of patients had moder- ately severe asthma and significant pulmonary impairment. Furthermore, whilst the authors would ... See full document

... induced asthma and asthma associated with allergic ...were montelukast is effective include asthma in obese patients, asthma in smokers, aspirin induced asthma and viral induced ... See full document

... When asthma control days (ACDs) were used as an outcome, higher baseline eNO levels, greater salbutamol use, and more positive aeroallergen skin test responses, in addition to fewer ACDs at baseline, predicted ... See full document

... reliever therapy has been shown to be well tolerated and not associated with increased safety concerns, with lower or similar incidence of death and asthma-related SAEs compared with the fixed-dose ... See full document

... Sample size was small, to detect small but potentially significant difference. Our is a open label trial, duration of study was short, COPD cases due to other causes were not included, also had less women sample. The ... See full document